{"nctId":"NCT02548832","briefTitle":"Bezafibrate Plus Berberine in Mixed Dyslipidemia","startDateStruct":{"date":"2013-04"},"conditions":["Mixed Dyslipidemia"],"count":36,"armGroups":[{"label":"Berberine","type":"EXPERIMENTAL","interventionNames":["Drug: Berberine"]},{"label":"Bezafibrate","type":"EXPERIMENTAL","interventionNames":["Drug: Bezafibrate"]},{"label":"Berberine plus Bezafibrate","type":"EXPERIMENTAL","interventionNames":["Drug: Berberine plus Bezafibrate"]}],"interventions":[{"name":"Berberine","otherNames":[]},{"name":"Bezafibrate","otherNames":[]},{"name":"Berberine plus Bezafibrate","otherNames":["Berberine, bezafibrate"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nA. Men and women\n\nB. Accomplished age 30 to 60 years\n\nC. Diagnosis of mixed dyslipidemia established to meet the following criteria:\n\n* Total cholesterol \\> 5,17 mmol/l.\n* Triglycerides \\> 1,7 mmol/l.\n\nD. BMI of 25 kg / m\\^2 to 39.9 kg / m\\^2, weight stable over the past three months, defined as a variability in the lower body weight of 5%.\n\nE. No drug treatment for lipid profile 3 months prior to baseline.\n\nF. Women must ensure a non-hormonal method to avoid pregnancy during the study period.\n\nG. Written information consent\n\nExclusion Criteria:\n\nA. Removal for informed consent letter\n\nB. Loss of monitoring\n\nC. Presence of serious adverse event\n\nD. Adherence to treatment \\<80%\n\nE. Consumption of drugs known about lipid profile, glucose metabolism, blood pressure and body weight during the intervention period influence\n\nF. Intolerance or not tolerability or hypersensitivity to the compounds used in the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"60 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Triglycerides After 90 Days","description":"The blood sample for the determination of triglycerides was taken after an overnight fast and was evaluated at baseline and after 90 days by spectrophotometry method.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"0.9"},{"groupId":"OG001","value":"1.1","spread":"0.4"},{"groupId":"OG002","value":"1.3","spread":"0.7"}]}]}]},{"type":"PRIMARY","title":"Total Cholesterol After 90 Days.","description":"The blood sample for the determination of total cholesterol was taken after an overnight fast and was evaluated at baseline and after 90 days by spectrophotometry method.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.3","spread":"0.5"},{"groupId":"OG001","value":"5.8","spread":"0.8"},{"groupId":"OG002","value":"4.6","spread":"1.2"}]}]}]},{"type":"PRIMARY","title":"Low Density Lipoprotein Cholesterol (LDL-c) After 90 Days","description":"The blood sample for the determination of low density lipoprotein cholesterol was taken after an overnight fast and was evaluated at baseline and after 90 days by spectrophotometry method.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"0.8"},{"groupId":"OG001","value":"2.4","spread":"0.6"},{"groupId":"OG002","value":"2.2","spread":"1.3"}]}]}]},{"type":"PRIMARY","title":"High Density Lipoprotein Cholesterol (HDL-c) After 90 Days","description":"The blood sample for the determination of high density lipoprotein cholesterol was taken after an overnight fast and was evaluated at baseline and after 90 days by spectrophotometry method.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":"0.3"},{"groupId":"OG001","value":"2.0","spread":"0.3"},{"groupId":"OG002","value":"1.8","spread":"0.5"}]}]}]},{"type":"PRIMARY","title":"Very Low Density Lipoprotein After 90 Days","description":"The blood sample for the determination of VLDL was taken after an overnight fast and was calculated at baseline and after 90 days as triglycerides/5.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"0.1"},{"groupId":"OG001","value":"0.2","spread":"0.0"},{"groupId":"OG002","value":"0.2","spread":"0.1"}]}]}]},{"type":"SECONDARY","title":"Body Weight (BW) After 90 Days","description":"The body weight was evaluated at baseline and after 90 days after an overnight fast, through a bioimpedance digital scale results are reported in kilograms with a decimal.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"75.4","spread":"10.2"},{"groupId":"OG001","value":"83.6","spread":"10.7"},{"groupId":"OG002","value":"73.0","spread":"6.2"}]}]}]},{"type":"SECONDARY","title":"Body Mass Index (BMI) After 90 Days","description":"The BMI was calculated at baseline and after 90 days by the square of the body height, and is universally expressed in units of kg/m\\^2, resulting from mass in kilograms and height in metres.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.6","spread":"4.4"},{"groupId":"OG001","value":"31.8","spread":"3.4"},{"groupId":"OG002","value":"28.4","spread":"2.8"}]}]}]},{"type":"SECONDARY","title":"Waist Circumference (WC) After 90 Days","description":"The waist circumference was evaluated at baseline and after 90 days after an overnight fast with a flexible tape in the midpoint between the lowest rib and the iliac crest and is expressed in centimeters.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"94.0","spread":"11.2"},{"groupId":"OG001","value":"98.0","spread":"12.0"},{"groupId":"OG002","value":"88.7","spread":"9.2"}]}]}]},{"type":"SECONDARY","title":"Systolic Blood Pressure After 90 Days","description":"The systolic blood pressure was evaluated at baseline and after 90 days with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of SBP. The value was expressed on mmHg.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"122","spread":"10"},{"groupId":"OG001","value":"122","spread":"13"},{"groupId":"OG002","value":"114","spread":"10"}]}]}]},{"type":"SECONDARY","title":"Diastolic Blood Pressure After 90 Days","description":"The diastolic blood pressure was evaluated at baseline and after 90 days with a digital sphygmomanometer with the subject sited down on a chair after a resting period of 5 minutes on three occasions. The mean of the three measures was considered as the value of DBP. The value was expressed on mmHg.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73","spread":"8"},{"groupId":"OG001","value":"74","spread":"11"},{"groupId":"OG002","value":"72","spread":"10"}]}]}]},{"type":"SECONDARY","title":"Fasting Serum Glucose (FSG) After 90 Days","description":"The glucose oxidase technique (Beckman Instruments, Inc., Brea, California, USA) was used to determine fasting serum glucose at baseline and after 90 days with an intra- and interassay coefficient of variation of \\<1.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.6","spread":"0.4"},{"groupId":"OG001","value":"5.5","spread":"0.5"},{"groupId":"OG002","value":"5.3","spread":"0.3"}]}]}]},{"type":"SECONDARY","title":"Uric Acid After 90 Days","description":"The blood sample for the determination of uric acid was taken after an overnight fast and was evaluated at baseline and after 90 days by spectrophotometry method.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"285.5","spread":"166.5"},{"groupId":"OG001","value":"350.9","spread":"53.5"},{"groupId":"OG002","value":"279.5","spread":"89.2"}]}]}]},{"type":"SECONDARY","title":"Creatinine After 90 Days","description":"The blood sample for the determination of creatinine was taken after an overnight fast and was evaluated at baseline and after 90 days by spectrophotometry method.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53.0","spread":"26.5"},{"groupId":"OG001","value":"44.2","spread":"35.4"},{"groupId":"OG002","value":"61.9","spread":"35.4"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":["Dyspepsia","Headache","Nausea"]}}}